Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
ChemGenex Pharmaceuticals is a pharmaceutical development company dedicated to improving the lives of patients by developing therapeutics in the areas of oncology, diabetes, obesity, and depression. ChemGenex harnesses the power of genomics for target discovery and validation, and in clinical trials to develop more individualized therapeutic outcomes. ChemGenex’s lead compound, Ceflatonin®, is currently in phase 2 clinical trials for leukemia and Quinamed® is in phase 2 clinical trials for prostate, breast and ovarian cancers. The company has a significant portfolio of anti-cancer, diabetes, obesity and depression programs, several of which have been partnered with international pharmaceutical ( www.chemgenex.com )
ChemGenex Pharmaceuticals Limited
3475 Edison Way Suite M
Menlo Park, California 94025
USA
Tel: (650) 474-9800
Fax: (650) 474-9808